首页> Anticancer research> Impact of a 21-Gene Recurrence Score Test on the Choice of Adjuvant Chemotherapy for Hormone Receptor-positive Early-stage Breast Cancer: A Prospective Study.

Impact of a 21-Gene Recurrence Score Test on the Choice of Adjuvant Chemotherapy for Hormone Receptor-positive Early-stage Breast Cancer: A Prospective Study.

导出原文传递

翻译打印收藏纠错

第一作者： Yinduo,Zeng

第一单位： Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Breast Cancer Tumor Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, P.R. China.

作者： Yinduo,Zeng ^[1] ; Qian,Li ^[1] ; Tao,Qin ^[2] ; Shunrong,Li ^[1] ; Liang,Jin ^[1] ; Jiannan,Wu ^[1] ; Kai,Chen ^[1] ; Heran,Deng ^[1] ; Nanyan,Rao ^[1] ; Qiang,Liu ^[1] ; Fengxi,Su ^[1] ; Weijuan,Jia ^[3] ; Herui,Yao ^[4]

作者单位： Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Breast Cancer Tumor Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, P.R. China. ^[1] Department of Medical Oncology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, P.R. China. ^[2] Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Breast Cancer Tumor Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, P.R. China yaoherui@163.com jiaweijuan@aliyun.com. ^[3] Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Breast Cancer Tumor Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, P.R. China yaoherui@163.com jiaweijuan@aliyun.com.;Department of Medical Oncology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, P.R. China. ^[4]

关键词 21-gene score Breast cancer Ki67 adjuvant chemotherapy early stage